PATRICK MCGARRAH, M.D.
Medical Oncology Physician · ROCHESTER, MN
Individual Active NPI 1417489527
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 454 | 71,564 | $5,883,073 | $1,937,010 | $1,544,052 |
| 2023 | 99 | 1,152 | $176,773 | $61,493 | $48,992 |
| 2022 | 74 | 131 | $50,251 | $20,028 | $15,765 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1453 | Injection, fosaprepitant, 1 mg | 8,100 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 7,400 | $53 | $42 |
| J9267 | Injection, paclitaxel, 1 mg | 6,696 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 5,762 | $50 | $40 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 4,400 | $0 | $0 |
| J9305 | Injection, pemetrexed, not otherwise specified, 10 mg | 1,240 | $5 | $4 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,184 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 890 | $1 | $1 |
| J9041 | Injection, bortezomib, 0.1 mg | 780 | $2 | $1 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 596 | $0 | $0 |
| 96375 | Injection of additional new drug or substance into vein | 346 | $16 | $13 |
| J9045 | Injection, carboplatin, 50 mg | 297 | $4 | $3 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | 64145 | MN |
| Internal Medicine Physician | 207R00000X | 64145 | MN | |
| Hematology & Oncology Physician | 207RH0003X | 64145 | MN |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Minnesota
- NPI 1437278959
- NPI 1003376468
- NPI 1982680583
- NPI 1801877501
- NPI 1437136553
- NPI 1417148180
- NPI 1306879028
- NPI 1265729834
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.